Andries G - Search Results

1

Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists.

Karass M, Chugh S, Andries G, Mamorska-Dyga A, Nelson JC, Chander PN. Karass M, et al. Among authors: andries g. Stem Cell Investig. 2017 May 26;4:43. doi: 10.21037/sci.2017.05.05. eCollection 2017. Stem Cell Investig. 2017. PMID: 28607917 Free PMC article.

2

Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.

Andries G, Karass M, Yandrapalli S, Linder K, Liu D, Nelson J, Pawar R, Chugh S. Andries G, et al. Exp Hematol Oncol. 2017 Jan 13;6:4. doi: 10.1186/s40164-017-0064-7. eCollection 2017. Exp Hematol Oncol. 2017. PMID: 28101432 Free PMC article.

3

Drug Therapy of Dyslipidemia in the Elderly.

Yandrapalli S, Gupta S, Andries G, Cooper HA, Aronow WS. Yandrapalli S, et al. Among authors: andries g. Drugs Aging. 2019 Apr;36(4):321-340. doi: 10.1007/s40266-018-00632-x. Drugs Aging. 2019. PMID: 30613912 Review.

4

Benefit-risk review of different drug classes used in chronic heart failure.

Andries G, Yandrapalli S, Aronow WS. Andries G, et al. Expert Opin Drug Saf. 2019 Jan;18(1):37-49. doi: 10.1080/14740338.2018.1512580. Epub 2018 Aug 31. Expert Opin Drug Saf. 2019. PMID: 30114943 Review.

5

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives.

Yandrapalli S, Andries G, Biswas M, Khera S. Yandrapalli S, et al. Among authors: andries g. Vasc Health Risk Manag. 2017 Oct 5;13:369-382. doi: 10.2147/VHRM.S114784. eCollection 2017. Vasc Health Risk Manag. 2017. PMID: 29042791 Free PMC article. Review.

6

Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.

Andries G, Yandrapalli S, Naidu SS, Panza JA. Andries G, et al. Cardiol Rev. 2018 Sep/Oct;26(5):239-244. doi: 10.1097/CRD.0000000000000211. Cardiol Rev. 2018. PMID: 29746257 Review.

7

Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agents.

Yandrapalli S, Andries G, Gupta S, Dajani AR, Aronow WS. Yandrapalli S, et al. Among authors: andries g. Expert Opin Investig Drugs. 2019 Mar;28(3):223-234. doi: 10.1080/13543784.2019.1559814. Epub 2018 Dec 22. Expert Opin Investig Drugs. 2019. PMID: 30580647 Review.

8

Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy.

Yandrapalli S, Harikrishnan P, Andries G, Aronow WS, Panza JA, Naidu SS. Yandrapalli S, et al. Among authors: andries g. J Invasive Cardiol. 2022 Jan;34(1):E8-E13. Epub 2021 Dec 12. J Invasive Cardiol. 2022. PMID: 34919530 Free article.

9

Complete versus culprit only revascularization in ST-elevation myocardial infarction-a perspective on recent trials and recommendations.

Andries G, Khera S, Timmermans RJ, Aronow WS. Andries G, et al. J Thorac Dis. 2017 Jul;9(7):2159-2167. doi: 10.21037/jtd.2017.06.95. J Thorac Dis. 2017. PMID: 28840017 Free PMC article. Review.

10

DAPT Duration: When Less Is More.

Cohen M, Andries G. Cohen M, et al. Among authors: andries g. Cardiovasc Revasc Med. 2020 Dec;21(12):1507-1508. doi: 10.1016/j.carrev.2020.09.018. Epub 2020 Sep 16. Cardiovasc Revasc Med. 2020. PMID: 33071197 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page